Subcommittee for Dose Reconstruction Reviews (SDRR), Advisory Board on Radiation and Worker Health (ABRWH or the Advisory Board), National Institute for Occupational Safety and Health (NIOSH), 19186-19187 [2016-07624]
Download as PDF
<![CDATA[
19186
Federal Register / Vol. 81, No. 64 / Monday, April 4, 2016 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
mstockstill on DSK4VPTVN1PROD with NOTICES
Advisory Committee to the Director
(ACD), Centers for Disease Control and
Prevention—Health Disparities
Subcommittee (HDS)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned subcommittee:
Time and Date: 8:30 a.m.–4:30 p.m.,
EDT, April 28, 2016.
Place: CDC, Building 19, Rooms 256/
257, 1600 Clifton Road NE., Atlanta,
Georgia 30329.
Status: Open to the public, limited
only by the space available. The meeting
room accommodates approximately 50
people. The public is welcome to
participate during the public comment
period, which is tentatively scheduled
from 4:00 p.m. to 4:15 p.m. This
meeting is also available by
teleconference. Please dial (866) 763–
0273 and enter code 6158968.
Purpose: The Subcommittee will
contribute to the ACD’s advice to the
CDC Director on strategic and other
health disparities and health equity
issues and provide guidance on
opportunities for CDC.
Matters for Discussion: The Health
Disparities Subcommittee members will
discuss progress toward the
Subcommittee’s input to the ACD on
disparity issues related to
environmental health.
The agenda is subject to change as
priorities dictate.
Web links:
Windows Media: https://
wm.onlinevideoservice.com/CDC1.
Flash: https://
www.onlinevideoservice.com/clients/
CDC/?mount=CDC3.
Smart Phones and Mobile devices:
https://
wowza01.sea.onlinevideoservice.com/
live/CDC3/playlist.m3u8.
If you are unable to connect using the
link, copy and paste the link into your
web browser.
Number for Technical Support: 404–
639–3737.
Contact Person for More Information:
Leandris Liburd, Ph.D., M.P.H., M.A.,
Designated Federal Officer, Health
Disparities Subcommittee, Advisory
Committee to the Director, CDC, 1600
Clifton Road, NE., M/S K–77, Atlanta,
Georgia 30329 Telephone (770) 488–
8343, Email: LEL1@cdc.gov.
VerDate Sep<11>2014
19:03 Apr 01, 2016
Jkt 238001
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2016–07527 Filed 4–1–16; 8:45 am]
BILLING CODE 4163–18–P
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting for the initial
review of applications in response to
Funding Opportunity Announcement
(FOA), RFA–CE–16–003, Research on
Prescription Opioid Use, Opioid
Prescribing, and Associated Heroin
Risk.
Time and Date: 8:30 a.m.–5:00 p.m.,
EDT, April 27–28, 2016 (Closed).
Place: Atlanta Marriott Century
Center, 2000 Century Blvd. NE., Atlanta,
Georgia 30345.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters for Discussion: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘Research on Prescription Opioid Use,
Opioid Prescribing, and Associated
Heroin Risk’’, FOA RFA–CE–16–003.
Contact Person for More Information:
M. Chris Langub, Ph.D., Scientific
Review Officer, CDC, 4770 Buford
Highway NE., Mailstop F–80, Atlanta,
Georgia 30341, Telephone: (770) 488–
3585, EEO6@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
Frm 00075
Fmt 4703
Catherine Ramadei,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2016–07626 Filed 4–1–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
PO 00000
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Sfmt 4703
Subcommittee for Dose
Reconstruction Reviews (SDRR),
Advisory Board on Radiation and
Worker Health (ABRWH or the
Advisory Board), National Institute for
Occupational Safety and Health
(NIOSH)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting for the
aforementioned subcommittee:
Time and Date: 10:30 a.m.–5:00 p.m.,
EDT, April 28, 2016.
Place: Audio Conference Call via FTS
Conferencing.
Status: Open to the public, but
without a public comment period. The
public is welcome to submit written
comments in advance of the meeting, to
the contact person below. Written
comments received in advance of the
meeting will be included in the official
record of the meeting. The public is also
welcome to listen to the meeting by
joining the teleconference at the USA
toll-free, dial-in number at 1–866–659–
0537 and the pass code is 9933701.
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation
Program Act of 2000 to advise the
President on a variety of policy and
technical functions required to
implement and effectively manage the
new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines that
have been promulgated by the
Department of Health and Human
Services (HHS) as a final rule; advice on
methods of dose reconstruction, which
have also been promulgated by HHS as
a final rule; advice on the scientific
validity and quality of dose estimation
and reconstruction efforts being
performed for purposes of the
compensation program; and advice on
E:\FR\FM\04APN1.SGM
04APN1
mstockstill on DSK4VPTVN1PROD with NOTICES
Federal Register / Vol. 81, No. 64 / Monday, April 4, 2016 / Notices
petitions to add classes of workers to the
Special Exposure Cohort.
In December 2000, the President
delegated responsibility for funding,
staffing, and operating the Advisory
Board to HHS, which subsequently
delegated this authority to CDC. NIOSH
implements this responsibility for CDC.
The charter was issued on August 3,
2001, renewed at appropriate intervals,
and will expire on August 3, 2017.
Purpose: The Advisory Board is
charged with (a) providing advice to the
Secretary, HHS, on the development of
guidelines under Executive Order
13179; (b) providing advice to the
Secretary, HHS, on the scientific
validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advise the Secretary on
whether there is a class of employees at
any Department of Energy facility who
were exposed to radiation but for whom
it is not feasible to estimate their
radiation dose, and on whether there is
reasonable likelihood that such
radiation doses may have endangered
the health of members of this class. The
Subcommittee for Dose Reconstruction
Reviews was established to aid the
Advisory Board in carrying out its duty
to advise the Secretary, HHS, on dose
reconstruction.
Matters for Discussion: The agenda for
the Subcommittee meeting includes the
following dose reconstruction program
quality management and assurance
activities: Dose reconstruction cases
under review from Sets 14–18,
including the Oak Ridge sites (Y–12, K–
25, Oak Ridge National Laboratory, and
Savannah River Site; preparation of the
Advisory Board’s next report to the
Secretary, HHS, summarizing the results
of completed dose reconstruction
reviews.
The agenda is subject to change as
priorities dictate.
Contact Person for More Information:
Theodore Katz, Designated Federal
Officer, NIOSH, CDC, 1600 Clifton
Road, Mailstop E–20, Atlanta, Georgia
30333, Telephone (513) 533–6800, Toll
Free 1(800) CDC–INFO, Email ocas@
cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
VerDate Sep<11>2014
19:03 Apr 01, 2016
Jkt 238001
Prevention and the Agency for Toxic
Substances and Disease Registry.
Catherine Ramadei,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2016–07624 Filed 4–1–16; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Community Living
Award of a Single Source NonCompeting Continuation Cooperative
Agreement for One National Activities
Grant Project Under Section 6 of the
Assistive Technology Act of 1998, as
Amended (ATAct)
Administration for Community
Living, HHS.
ACTION: Notice.
AGENCY:
As a result of the Workforce
Opportunity Improvement Act (Pub. L.
113–128) signed by President Obama in
July 2014, the Assistive Technology Act
Data Reporting and Analysis
cooperative agreement with the Center
for Assistive Technology Act Data
Assistance (CATADA) at the University
of Massachusetts—Boston, Institute for
Community Inclusion transferred from
the U.S. Department of Education,
Rehabilitation Services Administration
to the U.S. Department of Health and
Human Services, Administration for
Community Living (ACL). The CATADA
Project is a national technical assistance
grant for assistive technology programs
that provides a comprehensive and
state-specific, regional and national data
reporting system and resources to
entities funded under Section 4 of the
AT Act to improve the reporting of data
and performance measures for the
required state-level and state leadership
activities, and to provide appropriate
information to entities not funded under
the AT Act to improve awareness of and
access to assistive technology. The
Department of Health and Human
Services is currently transitioning and
developing the information collection
instruments for the State Grant for AT
programs under Section 4 of the AT Act
to ACL.
The CATADA Project provides
training and technical assistance on the
use of an accessible national AT data
reporting system that supports a day-today information collection tool and an
aggregate report for the submission of
federally required data and performance
measures for all 56 State Grant for AT
programs under the AT Act.
SUMMARY:
PO 00000
Frm 00076
Fmt 4703
Sfmt 9990
19187
Program Name: Assistive Technology
National Activities.
Award Amount: up to $317,123 to
University of Massachusetts—Boston,
Institute for Community Inclusion.
Project Period: 9/30/2016 to 9/29/
2017.
Award Type: Cooperative Agreement.
Statutory Authority: This program is
authorized under Section 6 of the
Assistive Technology Act of 1998, as
amended (29 U.S.C. 3005).
Catalog of Federal Domestic
Assistance (CFDA) Number: 93.464
Discretionary Projects.
Dates: Estimated Project Period—
September 30, 2016 through September
29, 2017.
I. Program Description
The purpose of the National Activities
cooperative agreement with the
University of Massachusetts—Boston,
Institute for Community Inclusion is to
continue existing activities designed to
support and improve the administration
of the AT Act. The grantee will continue
to provide state-specific, regional and
national training and technical
assistance concerning information
reporting and analysis, develop state
and national data reports on the
activities carried out by the State Grant
for AT programs under Section 4 of the
AT Act and make the reports available
to ACL, stakeholders and the general
public.
Justification: ACL is currently
working on transitioning and
developing the Assistive Technology
National Activities data collection
instruments for the State Grant for AT
programs under Section 4 of the AT Act
to ACL. To ensure uninterrupted
continuation of data reporting and
analysis, ACL plans to issue a one year
single source non-competing
continuation cooperative agreement
award to the University of
Massachusetts—Boston, Institute for
Community Inclusion.
II. Agency Contact
For further information or comments
regarding this action, contact Lori
Gerhard, U.S. Department of Health and
Human Services, Administration for
Community Living, Center for Integrated
Programs, Office of Consumer Access
and Self-Determination, 330 C Street
SW., Washington, DC 20201; telephone
(202) 795–7348; fax (202) 205–0414;
email Lori.Gerhard@acl.hhs.gov.
Dated: March 29, 2016.
Kathy Greenlee,
Administrator and Assistant Secretary for
Aging.
[FR Doc. 2016–07652 Filed 4–1–16; 8:45 am]
BILLING CODE 4154–01–P
E:\FR\FM\04APN1.SGM
04APN1
]]>Agencies
[Federal Register Volume 81, Number 64 (Monday, April 4, 2016)]
[Notices]
[Pages 19186-19187]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-07624]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Subcommittee for Dose Reconstruction Reviews (SDRR), Advisory
Board on Radiation and Worker Health (ABRWH or the Advisory Board),
National Institute for Occupational Safety and Health (NIOSH)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC), announces the following meeting for the
aforementioned subcommittee:
Time and Date: 10:30 a.m.-5:00 p.m., EDT, April 28, 2016.
Place: Audio Conference Call via FTS Conferencing.
Status: Open to the public, but without a public comment period.
The public is welcome to submit written comments in advance of the
meeting, to the contact person below. Written comments received in
advance of the meeting will be included in the official record of the
meeting. The public is also welcome to listen to the meeting by joining
the teleconference at the USA toll-free, dial-in number at 1-866-659-
0537 and the pass code is 9933701.
Background: The Advisory Board was established under the Energy
Employees Occupational Illness Compensation Program Act of 2000 to
advise the President on a variety of policy and technical functions
required to implement and effectively manage the new compensation
program. Key functions of the Advisory Board include providing advice
on the development of probability of causation guidelines that have
been promulgated by the Department of Health and Human Services (HHS)
as a final rule; advice on methods of dose reconstruction, which have
also been promulgated by HHS as a final rule; advice on the scientific
validity and quality of dose estimation and reconstruction efforts
being performed for purposes of the compensation program; and advice on
[[Page 19187]]
petitions to add classes of workers to the Special Exposure Cohort.
In December 2000, the President delegated responsibility for
funding, staffing, and operating the Advisory Board to HHS, which
subsequently delegated this authority to CDC. NIOSH implements this
responsibility for CDC. The charter was issued on August 3, 2001,
renewed at appropriate intervals, and will expire on August 3, 2017.
Purpose: The Advisory Board is charged with (a) providing advice to
the Secretary, HHS, on the development of guidelines under Executive
Order 13179; (b) providing advice to the Secretary, HHS, on the
scientific validity and quality of dose reconstruction efforts
performed for this program; and (c) upon request by the Secretary, HHS,
advise the Secretary on whether there is a class of employees at any
Department of Energy facility who were exposed to radiation but for
whom it is not feasible to estimate their radiation dose, and on
whether there is reasonable likelihood that such radiation doses may
have endangered the health of members of this class. The Subcommittee
for Dose Reconstruction Reviews was established to aid the Advisory
Board in carrying out its duty to advise the Secretary, HHS, on dose
reconstruction.
Matters for Discussion: The agenda for the Subcommittee meeting
includes the following dose reconstruction program quality management
and assurance activities: Dose reconstruction cases under review from
Sets 14-18, including the Oak Ridge sites (Y-12, K-25, Oak Ridge
National Laboratory, and Savannah River Site; preparation of the
Advisory Board's next report to the Secretary, HHS, summarizing the
results of completed dose reconstruction reviews.
The agenda is subject to change as priorities dictate.
Contact Person for More Information: Theodore Katz, Designated
Federal Officer, NIOSH, CDC, 1600 Clifton Road, Mailstop E-20, Atlanta,
Georgia 30333, Telephone (513) 533-6800, Toll Free 1(800) CDC-INFO,
Email ocas@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Catherine Ramadei,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 2016-07624 Filed 4-1-16; 8:45 am]
BILLING CODE 4163-19-P
